Table 2.
Mean rank ordering (1 = highest) of preferred current and future prevention products among MSM in three US cities, 2018 (n = 782)
| LA Injectable | Daily Pill* | Condom* | Event Pills | Anal Gel | Anal Suppository | |
|---|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |
| Overall | 3.04 (2.30) | 3.45 (2.22) | 3.52 (2.58) | 3.82 (2.04) | 5.33 (1.83) | 5.51 (1.79) |
| Current daily PrEP use | ||||||
| Yes | 2.08 (1.48) a | 2.17 (1.33) a | 4.53 (2.47) a | 4.07 (1.96) a | 5.75 (1.54) a | 5.81 (1.64) a |
| No | 3.45 (2.46) | 4.07 (2.31) | 3.11 (2.51) | 3.69 (2.05) | 5.13 (1.94) | 5.37 (1.85) |
| Unprotected (condomless/PrEPless) anal sex (3 months) | ||||||
| Yes | 3.05 (2.25) | 3.57 (2.30) | 3.75 (2.74) | 3.62 (2.02) a | 5.35 (1.80) | 5.30 (1.86) a |
| No | 3.04 (2.33) | 3.38 (2.18) | 3.39 (2.47) | 3.94 (2.03) | 5.32 (1.85) | 5.62 (1.75) |
| Race/ethnicity | ||||||
| Black | 3.54 (2.45) b , f | 3.34 (2.12) d , f | 2.83 (2.29) b , d | 3.60 (1.93) | 5.16 (1.77) b , c , f | 5.20 (1.78) b |
| Hispanic/Latino | 2.99 (2.31) | 3.64 (2.27) | 3.40 (2.57) | 3.94 (2.21) | 5.15 (1.87) | 5.57 (1.82) |
| White | 2.77 (2.21) | 3.27 (2.15) | 3.81 (2.61) | 3.86 (1.99) | 5.57 (1.78) | 5.65 (1.77) |
| Other | 3.54 (2.66) | 4.14 (2.47) | 3.51 (2.67) | 3.87 (2.16) | 4.78 (1.94) | 5.27 (1.81) |
| Age group, years | ||||||
| 18 to 29 | 3.16 (2.33) a , c | 3.46 (2.15) c , † | 3.06 (2.33) a , b | 3.79 (2.02) | 5.39 (1.88) b , c | 5.68 (1.75) b , c |
| 30 to 39 | 2.51 (2.07) | 3.28 (2.23) | 3.83 (2.59) | 3.86 (1.97) | 5.49 (1.74) | 5.71 (1.69) |
| 40+ | 3.52 (2.41) | 3.66 (2.34) | 3.99 (2.85) | 3.84 (2.17) | 4.98 (1.83) | 4.90 (1.88) |
| Education level | ||||||
| ≤ Post HS | 3.42 (2.41) a , b | 3.35 (2.21) | 3.22 (2.51) b | 3.95 (2.12) | 5.05 (1.87) a , b | 5.41 (1.74) |
| 4‐year college degree | 2.84 (2.17) | 3.47 (2.23) | 3.57 (2.59) | 3.84 (1.93) | 5.43 (1.83) | 5.56 (1.87) |
| ≥Post college | 2.81 (2.24) | 3.54 (2.23) | 3.85 (2.62) | 3.64 (2.05) | 5.56 (1.75) | 5.59 (1.75) |
| City/MSA | ||||||
| Atlanta | 3.03 (2.25) | 3.40 (2.27) | 3.88 (2.70) a , b , † | 3.83 (2.04) | 5.21 (1.86) b , † | 5.48 (1.81) |
| Detroit | 3.18 (2.37) | 3.35 (2.03) | 3.19 (2.40) | 3.77 (2.07) | 5.26 (1.82) | 5.65 (1.78) |
| New York | 2.95 (2.29) | 3.59 (2.34) | 3.45 (2.57) | 3.86 (2.00) | 5.52 (1.80) | 5.41 (1.79) |
HS, high school; LA, long acting; MSA, metropolitan statistical area; SD, standard deviation.
a
Row 1 vs. 2 within variable significantly different, p < 0.05
b
row 1 vs. 3 different, p < 0.05
c
row 2 vs. 3 different, p < 0.05
d
row 1 vs. 4 different, p < 0.05
e
row 2 vs. 4 different, p < .05
f
row 3 vs. 4 different, p < 0.05
*
Daily pill and condoms are prevention products currently available and recommended for use.
†
p < .10 for the single immediately preceding test comparison noted.